Myriad Genetics Inc (MYGN)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	585,400	517,000	476,400	493,000	378,800
Revenue	US$ in thousands	837,600	753,200	678,400	690,600	557,000
Gross profit margin		69.89%	68.64%	70.22%	71.39%	68.01%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $585,400K ÷ $837,600K
= 69.89%

The gross profit margin of Myriad Genetics Inc has shown a generally positive trend over the last five years. It increased from 68.01% as of December 31, 2020, to 71.39% by the end of December 31, 2021. This substantial uptick indicates improved efficiency in generating revenue after accounting for the cost of goods sold. Subsequently, the margin slightly decreased to 70.22% by December 31, 2022, but still remained at healthy levels.

However, there was a further decline in the gross profit margin to 68.64% as of December 31, 2023. This decrease may merit closer scrutiny to identify potential causes that could be impacting the cost structure and revenue generation of the company. The most recent data point, as of December 31, 2024, shows a partial recovery with the margin rising to 69.89%.

Overall, while the trend is positive on a long-term basis, the slight fluctuations in recent years suggest the need for continued monitoring of Myriad Genetics Inc's cost management and revenue generation strategies to ensure sustained profitability and competitiveness in the market.